Search research articles
Contact Us
Filters
Showing results (1-10 of 70) with videos related to
Page
of 7
Sort By:
Acta Orthopaedica
|
November 13, 2012
Validity, reliability, and responsiveness of a self-reported foot and ankle score (SEFAS)
Jill Dawson, Grahame Lavis
Rheumatology (Oxford, England)
|
April 11, 2026
Comment on: A systematic review of patient-reported outcome measures in patients with anti-neutrophil cytoplasmic antibody associated vasculitis
Joanna C Robson, Jill Dawson
The Lancet. Rheumatology
|
January 22, 2024
Assessing glucocorticoid toxicity: are the measures sensitive enough?
Joanna C Robson, Jill Dawson, Mwidimi Ndosi
Health and Quality of Life Outcomes
|
July 31, 2013
What is the optimal time point to assess patient-reported recovery after hip and knee replacement? A systematic review and analysis of routinely reported outcome data from the English patient-reported outcome measures programme
John Patrick Browne, Hamad Bastaki, Jill Dawson
The Knee
|
December 1, 2005
A response to issues raised in a recent paper concerning the Oxford knee score
Jill Dawson, Ray Fitzpatrick, David Murray, et al.
Journal of Aging and Physical Activity
|
August 29, 2007
Perceived barriers to walking in the neighborhood environment: a survey of middle-aged and older adults
Jill Dawson, Melvyn Hillsdon, Irene Boller, et al.
Archives of Orthopaedic and Trauma Surgery
|
January 10, 2008
The Oxford shoulder score revisited
Jill Dawson, Katherine Rogers, Ray Fitzpatrick, et al.
British Journal of Sports Medicine
|
May 2, 2007
Perceived barriers to walking in the neighbourhood environment and change in physical activity levels over 12 months
Jill Dawson, Melvyn Hillsdon, Irene Boller, et al.
Arthritis and Rheumatism
|
October 17, 2002
Comparison of clinical and patient-based measures to assess medium-term outcomes following shoulder surgery for disorders of the rotator cuff
Jill Dawson, Graham Hill, Ray Fitzpatrick, et al.
Gastroenterology Report
|
March 1, 2015
Development of drugs for celiac disease: review of endpoints for Phase 2 and 3 trials
Klaus Gottlieb, Jill Dawson, Fez Hussain, et al.
Page
of 7
Search research articles
Search
Showing results (1-10 of 70) with videos related to
Sort By:
Page
of 7
Acta Orthopaedica
|
November 13, 2012
Validity, reliability, and responsiveness of a self-reported foot and ankle score (SEFAS)
Jill Dawson, Grahame Lavis
Rheumatology (Oxford, England)
|
April 11, 2026
Comment on: A systematic review of patient-reported outcome measures in patients with anti-neutrophil cytoplasmic antibody associated vasculitis
Joanna C Robson, Jill Dawson
The Lancet. Rheumatology
|
January 22, 2024
Assessing glucocorticoid toxicity: are the measures sensitive enough?
Joanna C Robson, Jill Dawson, Mwidimi Ndosi
Health and Quality of Life Outcomes
|
July 31, 2013
What is the optimal time point to assess patient-reported recovery after hip and knee replacement? A systematic review and analysis of routinely reported outcome data from the English patient-reported outcome measures programme
John Patrick Browne, Hamad Bastaki, Jill Dawson
The Knee
|
December 1, 2005
A response to issues raised in a recent paper concerning the Oxford knee score
Jill Dawson, Ray Fitzpatrick, David Murray, et al.
Journal of Aging and Physical Activity
|
August 29, 2007
Perceived barriers to walking in the neighborhood environment: a survey of middle-aged and older adults
Jill Dawson, Melvyn Hillsdon, Irene Boller, et al.
Archives of Orthopaedic and Trauma Surgery
|
January 10, 2008
The Oxford shoulder score revisited
Jill Dawson, Katherine Rogers, Ray Fitzpatrick, et al.
British Journal of Sports Medicine
|
May 2, 2007
Perceived barriers to walking in the neighbourhood environment and change in physical activity levels over 12 months
Jill Dawson, Melvyn Hillsdon, Irene Boller, et al.
Arthritis and Rheumatism
|
October 17, 2002
Comparison of clinical and patient-based measures to assess medium-term outcomes following shoulder surgery for disorders of the rotator cuff
Jill Dawson, Graham Hill, Ray Fitzpatrick, et al.
Gastroenterology Report
|
March 1, 2015
Development of drugs for celiac disease: review of endpoints for Phase 2 and 3 trials
Klaus Gottlieb, Jill Dawson, Fez Hussain, et al.
Page
of 7